Document Detail


Medical treatment of Parkinson's disease: today and the future.
MedLine Citation:
PMID:  20875369     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Idiopathic Parkinson's disease (PD) is the only neurodegenerative disorder for which highly effective symptomatic therapy is available. Although levodopa continues to be the gold standard of symptomatic efficacy for treatment of the cardinal motor features, its chronic use is associated with potentially disabling motor complications. This review provides a survey of the medication that can currently be utilized for pharmacological management of the motor and non-motor symptoms of Parkinson's disease. Focus is placed on recent and evolving studies evaluating symptomatic and neuroprotective effects of such medication, and on how such studies may impact the future management of Parkinson's disease.
Authors:
G Gárdián; L Vécsei
Related Documents :
11866339 - Cervical intramedullary tuberculoma: acute presentation and rapid response to medical t...
10587279 - Pharmacologic strategies for discontinuing benzodiazepine treatment.
6477089 - Cerebral palsy: a clinical approach.
7834269 - Recommended methods for the disposal of sanitary wastes from temporary field medical fa...
10687229 - A clinical review of drug-induced gingival overgrowths.
16670409 - Combined pharmacotherapies and behavioral interventions for alcohol dependence: the com...
6540409 - National need for neurologists: commentary on the gmenac report: (graduate medical educ...
21046529 - [treatment decisions in advanced cancer. an empirical-ethical study on physicians' crit...
342269 - Circles in spermatocyte chromatin loops. electron microscopy and agas-nors studies.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  48     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  633-42     Citation Subset:  IM    
Affiliation:
Department of Neurology, University of Szeged, Szeged, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Disparity between best scientific evidence and cardiovascular events.
Next Document:  Single-dose ticagrelor does not prolong the QT interval in healthy subjects.